ResearcherRenmin Hospital of Wuhan UniversityActive in the last 2 years
Qibin Song
Matched on ORCID iD 0000-0002-4350-0916; OpenAlex author ID A5100657185. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 4
- Tumor-derived CDHR2-enriched extracellular vesicles engage ANPEP on liver sinusoidal endothelial cells to facilitate transendothelial migration in PDAC. Co-author DOI 10.1016/j.canlet.2026.218774↗
- RUNX1-regulated ITGB1-enriched extracellular vesicles drive pancreatic cancer liver metastasis via fibrotic pre-metastatic niche formation. Co-author DOI 10.1186/s12967-026-08521-3↗
- Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. Co-author DOI 10.1016/j.canlet.2024.216696↗
- Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer. Last author DOI 10.3389/fgene.2020.612196↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rui Wang · 2 shared papers, 2026 · strength 0.55
- Paper RUNX1-regulated ITGB1-enriched extracellular vesicles drive pancreatic cancer liver metastasis via fibrotic pre-metasta… DOI 10.1186/s12967-026-08521-3↗
- Paper Tumor-derived CDHR2-enriched extracellular vesicles engage ANPEP on liver sinusoidal endothelial cells to facilitate tr… DOI 10.1016/j.canlet.2026.218774↗
- Ming Dong · 2 shared papers, 2026 · strength 0.55
- Paper RUNX1-regulated ITGB1-enriched extracellular vesicles drive pancreatic cancer liver metastasis via fibrotic pre-metasta… DOI 10.1186/s12967-026-08521-3↗
- Paper Tumor-derived CDHR2-enriched extracellular vesicles engage ANPEP on liver sinusoidal endothelial cells to facilitate tr… DOI 10.1016/j.canlet.2026.218774↗
- Luojun Chen · 2 shared papers, 2020–2024 · strength 0.39
- Pijiang Sun · 1 shared paper, 2026 · strength 0.28
- Yi Wang · 1 shared paper, 2026 · strength 0.28
- Qiang Chen · 1 shared paper, 2026 · strength 0.27
- Huaizhi Wang · 1 shared paper, 2026 · strength 0.27
- Pingfeng Zhang · 1 shared paper, 2024 · strength 0.23
- Hao Zuo · 1 shared paper, 2020 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.